Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Medication use evaluation: a work in progress.

L M Schrand¹, K A Behmer-Miller, M B Ross

¹University of Iowa Hospitals and Clinics, Department of Pharmaceutical Care, College of Pharmacy, Iowa City, USA.

Pharmacy Practice Management Quarterly

|February 24, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Application packs.

British dental journal·2005

Same author

Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2003

Same author

Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.

Journal of chemotherapy (Florence, Italy)·2002

Same author

A cost-benefit analysis of RSV prophylaxis in high-risk infants.

The Annals of pharmacotherapy·2001

Same author

Sonographic appearance of appendicitis in a neutropenic pediatric patient after inversion appendectomy.

Pediatric radiology·2001

Same author

Evaluation of antimicrobial surgical prophylaxis with multiattribute utility theory.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001

Same journal

Survey of standards and guidelines for immunization delivery.

Pharmacy practice management quarterly·2001

Same journal

Somebody else's antibodies: the characteristics and roles of immune globulins.

Pharmacy practice management quarterly·2001

Same journal

Targeting vaccines based on underlying disease states.

Pharmacy practice management quarterly·2001

Same journal

Overcoming immunization disparities based on ethnicity.

Pharmacy practice management quarterly·2001

Same journal

Immunization and organ transplant donors and recipients.

Pharmacy practice management quarterly·2001

Same journal

Pregnancy and lactation in relation to vaccines and antibodies.

Pharmacy practice management quarterly·2001

See all related articles

The Medication Use Evaluation (MUE) Program at UIHC adapts to healthcare needs, showcasing its evolution and broad scope through long-standing and diverse initiatives. This program ensures optimal medication management in a tertiary care setting.

Area of Science:

Pharmacoeconomics
Clinical Pharmacy Practice
Health Services Research

Background:

The Medication Use Evaluation (MUE) Program at University of Iowa Hospitals and Clinics (UIHC) is designed to adapt to the evolving demands of a tertiary care institution.
Continuous program evolution is essential for maintaining high standards in medication management.

Purpose of the Study:

To provide a comprehensive overview of the MUE process at UIHC.
To illustrate the adaptability and scope of the MUE program through specific examples.

Main Methods:

Review of the established MUE process at UIHC.
Detailed examination of a long-standing MUE initiative since 1993.
Presentation of four additional MUE initiatives to demonstrate program breadth.

Related Experiment Videos

Main Results:

The MUE program at UIHC has a history of significant evolution.
Diverse medication classes are subject to MUE, including 5-HT3 receptor antagonists, alteplase, cefotaxime substitution, proton pump inhibitors, and COX-2 selective agents.

Conclusions:

The UIHC MUE Program effectively demonstrates adaptability and a wide scope in medication management.
The program's initiatives highlight its crucial role in optimizing medication use within a tertiary care setting.